Early screening and prevention of cervical cancer under precise medical background
10.3760/cma.j.cn431274-20190416-00440
- VernacularTitle:精准医疗背景下宫颈癌早期筛查及预防的研究进展
- Author:
Chen WANG
1
;
Zhuangzhuang LI
;
Xiaoting LIN
;
Nan YU
;
Qianqian GAO
;
Xiaohong QIU
Author Information
1. 哈尔滨医科大学附属第二医院妇产科 150081
- From:
Journal of Chinese Physician
2020;22(6):941-944
- CountryChina
- Language:Chinese
-
Abstract:
Cervical cancer is the second most common female reproductive system tumor in developing countries and ranks second among female cancer deaths worldwide. In recent years, with the continuous optimization and popularization of cervical cancer screening and preventive measures, the overall incidence rate of cervical cancer has decreased. But the incidence rate of cervical cancer in China is younger and differentiated. It continues to threaten the fertility, reproduction, mental health and life safety of women in China. In view of the current difficulties, precision medicine initiative (PMI) has opened a new chapter in the individualized prevention and treatment of cancer. Chinese medical workers need to learn from the beneficial results of international research organizations on early screening and prevention of cervical cancer, and explore the appropriate early screening and prevention strategies for cervical cancer in China.
